Pharma's Almanac

94 Articles Available

3 4

Outsourcing Trends in Small Molecule API Manufacturing

LSL-M07-14-NI-001

Pre-filled Syringe Technology Benefits Patients, Healthcare Providers and Drug Makers

CIO-M06-14-NI-001

As Outsourcing Relationships Evolve, Vaccine Production Will Continue to Shift to CMOs

LSL-M05-14-NI-002

Biologics Development Continues To Rise At Traditional Pharma Companies — What Does It Mean For Outsourcing?

CIO-M05-14-NI-001

Increased Demand for Vaccines will Continue to Benefit CMOs

CIO-M04-14-NI-001

2014 Trends in Strategic Outsourcing — Changes in the Qualities that Drive Outsourcing Partner Selection

CIO-M01-14-NI-001

Outsourcing To CROs And CMOs In Emerging Markets In 2014

CIO-M01-14-NI-002

What Can 2013 Outsourcing Trends Lead Us to Expect In 2014

LSL-M12-13-NI-001

API Manufacturing: Strategic Partnering Preferences with CMOs Vary Among Small Molecule, High Potency and Biologic API

CIO-M12-13-NI-001

Using 2013 Trends by Buyer Group to Plan Your Outsourcing Initiatives

CIO-M11-13-NI-001

With Outsourcing on the Rise, Why Isn’t Strategic Partnering Getting Easier?

LSL-M10-13-NI-001

Outsourcing Biomanufacturing

CIO-M09-13-NI-001

CROs and CMOs Continuing Drug Delivery Innovation

CIO-M08-13-NI-001

Essential Qualities Vary by Buyer Category and Business Size When it Comes to Outsourcing Relationships

CIO-M07-13-NI-001

Trends In Outsourcing — What’s Going On In Big Pharma

LSL-M06-13-NI-001

Outsourcing and the Oral Solid Dose: Will Challenges Lead to New Patterns of Outsourcing?

CIO-M06-13-NI-001

Competition Yields Benefits for Pharma Companies Outsourcing API Manufacturing

CIO-M05-13-NI-001

Quality and Reliability Will Continue to Drive Outsourcing Relationships in 2013

CIO-M04-13-NI-001

How Relevant are 483s in Terms of Compliance Perception?

CIO-M11-12-NI-001

Strategic Partnering for Innovation

CIO-M10-12-NI-001

Evolution in the Research Used for the CMO Awards

LSL-M10-12-NI-001

A Diversified Portfolio of Contract Providers Might Improve Results

LSL-M03-13-NI-002

The Right Preformulation / Formulation Outsourcing Partner Can Alleviate Challenges To Reducing Costs

CIO-M09-12-NI-001

Will A Focus On Innovation Pay Off For Custom Synthesis Providers?

CIO-M08-12-NI-001

3 4

CMO (3)